Solid Tumors (Phase 1) (DBCOND0081876)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06652529	Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients with Advanced Solid Tumors	No drug interventions	treatment	1	not_yet_recruiting
NCT02765165	Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)	Lomustine USL-311	treatment	1 / 2	terminated